Comparative study of natural antioxidants - curcumin, resveratrol and melatonin - in cadmium-induced oxidative damage in mice

被引:146
作者
Eybl, Vladislav [1 ]
Kotyzova, Dana [1 ]
Koutensky, Jaroslav [1 ]
机构
[1] Charles Univ Prague, Fac Med Pilsen, Dept Pharmacol & Toxicol, Plzen 30166, Czech Republic
关键词
antioxidants; cadmium; curcumin; melatonin; resveratrol; oxidative damage;
D O I
10.1016/j.tox.2006.05.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study was designed to examine the antioxidative effect of curcumin, resveratrol and melatonin pre-treatment on cadmium-induced oxidative damage and cadmium distribution in an experimental model in mice. Male CD mice were treated once daily for 3 days with curcumin (50mg/kg b.w., p.o.), resveratrol (20mg/kg b.w., p.o.) or melatonin (12mg/kg, p.o.), dispersed in 0.5% methylcellulose. One hour after the last dose of antioxidants cadmium chloride was administered (7 mg/kg b.w., s.c.) to pre-treated animals and control animals receiving methylcellulose. At 24th h after Cd administration the lipid peroxidation (LP - expressed as malondialdehyde production), reduced glutathione (GSH), catalase (CAT) and glutathione peroxidase (GPx) were estimated in liver homogenates. Cadmium concentration was-measured in the liver, kidneys, testes and brain by AAS. Cadmium chloride administration to mice induced hepatic lipid peroxidation (to 133%, p < 0.001), decreased GSH content (to 65%, p < 0.001) and inhibited catalase (to 68%, p < 0.001) and GPx activity (to 60%, p < 0.001) in the liver. Curcumin, resveratrol and melatonin oral pre-treatment completely prevented the Cd-induced lipid peroxidation and Cd-induced inhibition of GPx hepatic activity. Resveratrol was effective against Cd-induced inhibition of catalase activity (p < 0.001). The decrease in hepatic GSH level was not prevented by curcumin, resveratrol or melatonin pre-treatment. In mice treated with dritioxidants alone the level of LP, GSH, GPx or CAT was not different from control levels. The pre-treatment with antioxidants did not affect cadmium distribution in the tissues of Cd-intoxicated mice. The results demonstrate that curcumin, resveratrol and melatonin pre-treatment effectively protect against cadmium-induced lipid peroxidation and ameliorate the adverse effect of cadmium on antioxidant status without any reduction in tissue Cd burden. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:150 / 156
页数:7
相关论文
共 48 条
[1]  
Aggarwal BB, 2005, CRC SER MOD NUTR SCI, P349
[2]  
Aggarwal BB, 2004, ANTICANCER RES, V24, P2783
[3]   The chemistry of melatonin's interaction with reactive species [J].
Allegra, M ;
Reiter, RJ ;
Tan, DX ;
Gentile, C ;
Tesoriere, L ;
Livrea, MA .
JOURNAL OF PINEAL RESEARCH, 2003, 34 (01) :1-10
[4]   Cadmium-induced excretion of urinary lipid metabolites, DNA damage, glutathione depletion, and hepatic lipid peroxidation in Sprague-Dawley rats [J].
Bagchi, D ;
Bagchi, M ;
Hassoun, EA ;
Stohs, SJ .
BIOLOGICAL TRACE ELEMENT RESEARCH, 1996, 52 (02) :143-154
[5]   Induction of oxidative DNA damage by carcinogenic metals [J].
Bal, W ;
Kasprzak, KS .
TOXICOLOGY LETTERS, 2002, 127 (1-3) :55-62
[6]   Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins [J].
Belguendouz, L ;
Fremont, L ;
Linard, A .
BIOCHEMICAL PHARMACOLOGY, 1997, 53 (09) :1347-1355
[7]   Dietary antioxidants and cardiovascular disease [J].
Blomhoff, R .
CURRENT OPINION IN LIPIDOLOGY, 2005, 16 (01) :47-54
[8]  
Bludovská M, 1999, GEN PHYSIOL BIOPHYS, V18, P28
[9]   DNA oxidatively damaged by chromium(III) and H2O2 is protected by the antioxidants melatonin, N1-acetyl-N2-formyl-5-methoxykynuramine, resveratrol and uric acid [J].
Burkhardt, S ;
Reiter, RJ ;
Tan, DX ;
Hardeland, R ;
Cabrera, J ;
Karbownik, M .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (08) :775-783
[10]   Inhibition of free radical-induced peroxidation of rat liver microsomes by resveratrol and its analogues [J].
Cai, YJ ;
Fang, JG ;
Ma, LP ;
Yang, L ;
Liu, ZL .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2003, 1637 (01) :31-38